Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

There’s a BOGO Sale on Companhia Siderurgica Nacional (ADR) (SID)

Page 1 of 2
The world’s top value investors love it when their best stocks ideas are selling at bargain-basement prices. For those rarified investors, companies offering fire-sale prices become no-brainer buys. So regular investors like you and me would do well to emulate the masters and look at companies offering a “buy one, get one” sale on their stocks.
With the global economy still wallowing in a malaise from which it has yet to recover, it’s not surprising that Companhia Siderurgica Nacional (ADR) (NYSE:SID) , one of the largest vertically integrated steel companies in the world, let alone Brazil, is languishing. Even the once seemingly bulletproof economy of its home country could barely muster 1% growth last year, and 2013 isn’t looking too promising, either. Economists believe Brazil will be lucky to see 3% growth this year, a target below even the modest 4% GDP growth rate pegged by the government.
Companhia Siderurgica Nacional (ADR) (NYSE:SID)Since Companhia Siderurgica Nacional (ADR) (NYSE:SID) derives around 63% of its revenues from Brazilian markets and another 15% from Europe — which itself suffered a near 9% decline in demand for steel last year, according to ArcelorMittal (ADR) (NYSE: MT) — the fact that Companhia Siderurgica Nacional (ADR) (NYSE:SID)’s stock is down 51% from its 52-week high isn’t surprising. What might raise an eyebrow, though, is the high opinion of it still held by investors. Motley Fool CAPS shows that the steelmaker maintains an above-average four-star rating with 96% of the 924 members weighing in on it believing it will be able to outperform the broad market averages.
You’ll, of course, want to do your own due diligence before buying in to see if this is really a chance to pick up a quality stock at a severe discount, because you want to make sure there’s nothing seriously wrong with it before plugging it into your own portfolio.
Nerves of steel
Even in the face of the gloom that settled over the steel industry in 2012, there are plenty of indications that 2013 could be witness to the early stages of a larger recovery.
The U.S. housing market is regaining its footing with home prices rising while the combined sales of new and previously owned houses rose 9.9% last year. The automotive industry as well looks on pace to produce 15.38 million cars in 2013, well ahead of analyst expectations of 15.1 million vehicles.
China is also looking strong. The world’s second-largest economy snapped a seventh consecutive quarter streak of slower growth by posting GDP expansion of 7.9% in the fourth quarter, beating the 7.7% increase economists had anticipated. While that’s the slowest period of growth seen in more than a decade, it suggests that China may have finally bottomed out. That’s important for Companhia Siderurgica Nacional (ADR) (NYSE:SID) because Asia represents another 17% of its revenues.
Man of steel
According to the World Steel Association, global steel consumption is expected to rise 3.2% this year and even ArcelorMittal is looking for steel sales to rise 2% to 3% with iron ore sales up as much as 20%.
Europe remains the wild card with ministers there looking for capacity cuts of around 25% over the next three years. The contraction will allow the continent to remain competitive in the global steel industry, but that provides Companhia Siderurgica Nacional (ADR) (NYSE:SID) with an opening for expansion as it’s not subject to the same political vagaries as its rivals. ArcelorMittal, for example, was threatened with having its French plant nationalized unless it guaranteed workers wouldn’t lose their jobs if it closed two blast furnaces. An industry in contraction and saddled with onerous rules could be where CSN gets hot selling its wares.
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!